Interní Med. 2017; 19(3): 214-216 | DOI: 10.36290/int.2017.029

A long-term use of ivabradine in a middle-aged woman with chronic heart failure

MUDr. Jiří Leso
Kardiologická ordinace, Praha – Kyje

Longterm application ivabradine in middle-aged woman with chronic heart failure. Case report of a female patient who was monitoredfor a period of 18 eyars from the „innoncent“ beginnings until the clear morphological manifestation of a left ventricular non-compactcardiomyopathy with systolic dysfcuntion, which as preceded by a working diagnosis of idiopathic dilated cardiomyopathy. Theunfavourable development of chronic heart failure was reversed by decreasing the heart rate using ivabradine for 9 years.

Keywords: chronic heart failure, non-compaction cardiomyopathy, heart rate, ivabradine

Published: July 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Leso J. A long-term use of ivabradine in a middle-aged woman with chronic heart failure. Interní Med. 2017;19(3):214-216. doi: 10.36290/int.2017.029.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Pharmakokinetiks of ivabradine. Summary of product Characteristic. London, UK: EMEA, October 25, 2005.
    2. Swedberg K, Komajda M, Boehm M, et al. SHIFT Investigators. Ivabradine et outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 2010; 376: 875-885. Go to original source... Go to PubMed...
    3. Boehm M, Swedberg K, Komajda M et al. SHIFT Investigators. Heart rate as a risk factor in chronic heart failure (SHIFT): the associtation between heart rate at outcomes in a randomised placebo controlled trial. Lancet 2010; 376: 886-894. Go to original source... Go to PubMed...
    4. Leso J, Paleček T Chronické srdeční selhání u ženy středního věku při nonkompaktní kardiomyopatii. Kardiol Rev 2011; 13(3): 193-197.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.